logo
Select company
Select metric
$ -0.18EBIT per Share
VS
Market
35
Sector
72
Industry
87
History
40
$ 1.7Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -40.91M$ -0.181228.36M
3/31/2025$ -16.21M$ -0.071226.05M
12/31/2024$ -18.61M$ -0.091200.19M
9/30/2024$ -20.11M$ -0.111188.84M
6/30/2024$ -24.19M$ -0.131188.81M
3/31/2024$ -23.66M$ -0.131182.91M
12/31/2023$ -23.29M$ -0.131172.66M
9/30/2023$ -24.43M$ -0.141174.87M
6/30/2023$ -23.23M$ -0.141170.59M
3/31/2023$ -24.82M$ -0.151170.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -0.18.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average EBITPS has been $ -0.16.
  • The median EBITPS for LINEAGE CELL THERAPEUTICS INC during this period was $ -0.14
  • LINEAGE CELL THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -0.07.
  • The lowest EBITPS recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ -0.3

LINEAGE CELL THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
TVRD : TVARDI THERAPEUTICS INC $ -1.68CRBU : CARIBOU BIOSCIENCES INC $ -1.77SRZN : SURROZEN INC $ -4.06PRTA : PROTHENA CORP PUBLIC LTD CO $ -4.86FATE : FATE THERAPEUTICS INC $ -1.45KRRO : KORRO BIO INC $ -9.72CAPR : CAPRICOR THERAPEUTICS INC $ -1.53TNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -11.11OCGN : OCUGEN INC $ -0.19CRVO : CERVOMED INC $ -2.53

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for LINEAGE CELL THERAPEUTICS INC is calculated as follows: EBIT [ $ -26.44M ] / (Shares WA [ 149.97M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -0.18 ]

LCTX - EBIT per Share, Last 5 years

$ -0.3

Minimum

Jun 30, 2022

$ -0.07

Maximum

Mar 31, 2025

$ -0.16

Average

$ -0.14

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.72
max$ 10.76
average$ 1.16
median$ 0.38
std$ 3.42